Abstract
PurposePost hoc analysis of the phase III HAWK and HARRIER studies to compare the reductions in subretinal hyper-reflective material (SHRM) thickness following brolucizumab 6 mg or aflibercept 2 mg treatment...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have